UPDATE 1-Agenus brain cancer vaccine doubles survival rate in study

July 1, 2014 12:20 PM

13 0

July 1 (Reuters) - Agenus Inc said its experimental cancer vaccine helped brain tumor patients live nearly twice as long compared with those who received standard of care treatment.

The biotechnology company's shares jumped 23 percent to $3.96 before the bell.

Also read: Bayer says asbestos-related tumor treatment misses key goal

Read more

To category page